{
    "2018-09-06": [
        [
            {
                "time": "2018-09-15",
                "original_text": "Large Cap Pharma Stocks Staging a Comeback in Second Half",
                "features": {
                    "keywords": [
                        "Large Cap",
                        "Pharma",
                        "Comeback",
                        "Second Half"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "Recent Product Approvals Bode Well for Intuitive Surgical",
                "features": {
                    "keywords": [
                        "Product Approvals",
                        "Intuitive Surgical"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-10",
                "original_text": "Analyzing Intuitive Surgical’s Operational Performance",
                "features": {
                    "keywords": [
                        "Intuitive Surgical",
                        "Operational Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-15",
                "original_text": "What Alexion Pharmaceuticals’ Valuation Trend Indicates",
                "features": {
                    "keywords": [
                        "Alexion Pharmaceuticals",
                        "Valuation Trend"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-20",
                "original_text": "Johnson & Johnson To Present At Barclays Conference; Webcast At 12:45 PM ET",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Barclays Conference",
                        "Webcast"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "Johnson & Johnson To Present At Wells Fargo Conference; Webcast At 9:45 AM ET",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Wells Fargo Conference",
                        "Webcast"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "J&J Submits NDA to the FDA for Depression Drug in Adults",
                "features": {
                    "keywords": [
                        "J&J",
                        "NDA",
                        "FDA",
                        "Depression Drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}